Business
AI Drug Discovery Unicorn Insilico Medicine Jumps In Hong Kong Trading Debut
SOURCE:Forbes|BY:Zinnia Lee, Forbes Staff
After raising $293 million in the IPO, Insilico Medicine aims to become “a massive source of innovative drugs for pharma companies,” says founder Alex Zhavoronkov.
Failed to fetch content: Request failed with error code 403